MX9801089A - Proteina hibrida que comprende epitopes estimulantes de celula auxiliar t y epitopes de celula b de la proteina de membrana externa mayor chlamydia trachomatis y su uso como vacuna. - Google Patents

Proteina hibrida que comprende epitopes estimulantes de celula auxiliar t y epitopes de celula b de la proteina de membrana externa mayor chlamydia trachomatis y su uso como vacuna.

Info

Publication number
MX9801089A
MX9801089A MX9801089A MX9801089A MX9801089A MX 9801089 A MX9801089 A MX 9801089A MX 9801089 A MX9801089 A MX 9801089A MX 9801089 A MX9801089 A MX 9801089A MX 9801089 A MX9801089 A MX 9801089A
Authority
MX
Mexico
Prior art keywords
epitopes
hybrid protein
protein
chlamydia trachomatis
vaccine
Prior art date
Application number
MX9801089A
Other languages
English (en)
Inventor
Anne Villeneuve
Original Assignee
Immunova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunova filed Critical Immunova
Publication of MX9801089A publication Critical patent/MX9801089A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/295—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Chlamydiales (o)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se describe una proteína híbrida recombinante, la cual expresa por lo menos un epítope estimulante de neutralizacion de célula B de Chlamydia y un epítope de célula T auxiliar de Chlamydia, y es capaz de inducir anticuerpos inmunocorrectivos con Chlamydia trachomatis en vertebrados. También se describe una molécula deácido nucleico que comprende por lo menos una porcion que codifica la proteína híbrida recombinante y un anticuerpo inmunocorrectivo con C. trachomatis que se produce inmunizando un huésped con un componente inmunogénico que comprende la proteína híbrida recombinante a la molécula de ácido nucleico y un vehículo. La presente invencion se refiere a proteínas híbridas recombinantes, que contienen epítopes tanto de célula T auxiliar como de célula B, que se pueden usar como vacunas para proveer una respuesta protectora de serovars de C. trachomatis.
MX9801089A 1995-08-09 1998-02-09 Proteina hibrida que comprende epitopes estimulantes de celula auxiliar t y epitopes de celula b de la proteina de membrana externa mayor chlamydia trachomatis y su uso como vacuna. MX9801089A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9516293.9A GB9516293D0 (en) 1995-08-09 1995-08-09 Novel peptides and their use as vaccines

Publications (1)

Publication Number Publication Date
MX9801089A true MX9801089A (es) 1998-11-29

Family

ID=10778973

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9801089A MX9801089A (es) 1995-08-09 1998-02-09 Proteina hibrida que comprende epitopes estimulantes de celula auxiliar t y epitopes de celula b de la proteina de membrana externa mayor chlamydia trachomatis y su uso como vacuna.

Country Status (7)

Country Link
EP (1) EP0846176A1 (es)
AU (1) AU6653096A (es)
CA (1) CA2228522A1 (es)
GB (1) GB9516293D0 (es)
MX (1) MX9801089A (es)
NZ (1) NZ313950A (es)
WO (1) WO1997006263A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000003731A2 (en) * 1998-07-17 2000-01-27 Spectrum Medical Sciences Ltd. Oy Vaccine to prevent and treat chlamydial infections
ATE318924T1 (de) * 1998-12-04 2006-03-15 Univ Manitoba Zwei-schritte-verfahren zur impfung gegen chlamydia
US6448234B1 (en) 1998-12-08 2002-09-10 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6565856B1 (en) 1998-12-08 2003-05-20 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6447779B1 (en) 1998-12-08 2002-09-10 Corixa Corporation Compounds for the diagnosis of Chlamydial infection
US6555115B1 (en) 1998-12-08 2003-04-29 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6432916B1 (en) 1998-12-08 2002-08-13 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US6919187B2 (en) 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
DE60133190T2 (de) 2000-04-21 2009-04-02 CORIXA CORP., Wilmington Verbindungen und verfahren zur behandlung und diagnose von chlamydia-infektionen
EP1221317A1 (en) 2000-12-28 2002-07-10 SHAN-Beteiligungsgesellschaft m.b.H. Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins
CN103068837B (zh) 2010-05-28 2015-06-24 斯匹遐生物技术公司 嵌合momp抗原、方法和使用
RS60135B1 (sr) * 2013-03-18 2020-05-29 Statens Seruminstitut Vakcine protiv hlamidije sp.
JP2026504797A (ja) 2023-03-02 2026-02-10 サノフィ・パスツール クラミジア（Ｃｈｌａｍｙｄｉａ）の治療に使用するための組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994006827A1 (en) * 1992-09-18 1994-03-31 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Synthetic peptide vaccine for chlamydia trachomatis
AU6718394A (en) * 1993-05-13 1994-12-12 Connaught Laboratories Limited Hybrid picornaviruses expressing chlamydial epitopes

Also Published As

Publication number Publication date
CA2228522A1 (en) 1997-02-20
NZ313950A (en) 1999-09-29
EP0846176A1 (en) 1998-06-10
GB9516293D0 (en) 1995-10-11
AU6653096A (en) 1997-03-05
WO1997006263A1 (en) 1997-02-20

Similar Documents

Publication Publication Date Title
Batteiger et al. Partial protection against genital reinfection by immunization of guinea-pigs with isolated outer-membrane proteins of the chlamydial agent of guinea-pig inclusion conjunctivitis
NO924780L (no) Ekspresjon av spesifikke immunogener ved bruk av virusantigener
BR9712971A (pt) Método para produção de uma vacina para proteção de um hospedeiro contra doença causada com uma cadeia de chlamydia e composição imunológica
CA2295691A1 (en) Methods and compositions for impairing multiplication of hiv-1
WO1995029193A3 (en) Melanoma antigens
NO308413B1 (no) Antigen blanding, DNA-segment som koder for et antigen, rekombinant vektor og vertscelle som innbefatter DNA-segmentet samt anvendelser av et antigen
ATE359370T1 (de) Heterologe antigene in stämmen zur impfung mit lebendzellen
WO2002080851A3 (en) Chimeric vaccines
JP2003528887A5 (es)
KR910016343A (ko) 사람 파필로마바이러스(hpv) 16 단백질의 혈청반응성 에피토프
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
AU1800597A (en) Novel methods of vaccination and vaccines therefore comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope
ATE314087T1 (de) Impfstoffe mit erhöhter wirkung basierend auf chimären immunoglobulin e peptiden
WO1999013907A3 (en) Methods to improve immunogenicity of antigens and specificity of antibodies
AU3379693A (en) Vaccines and diagnostic assays for haemophilus influenzae
Chowdhury et al. Generation of high titer antisera in rabbits by DNA immunization
NZ500151A (en) A general method for attaching DNA molecule comprising non-antibody target molecule (eg. CTLA-4 or L-selectin), antigen or epitope sequence, and optionally a polypeptide sequence
ATE107516T1 (de) Pasteurella-impfstoff.
AU4803785A (en) Cross-reactive and protective epitopes of circumsporozoite proteins
Frenchick et al. Biochemical and immunological characterization of a novel peptide carrier system using rotavirus VP6 particles
AU2667600A (en) Identification of specific differentially expressed antigens
Arnon Synthetic Vaccines—A Dream or Reality
ATE374622T1 (de) Genetische impstoffe mit adjuvans
DE60025522D1 (de) Mycoplasma mycoides subsp. mycoides sc antigenisches lppq protein, seine herstellung und verwendung
BRPI0009746B8 (pt) molécula de veículo contendo plasmídeo pg-pviii compreendendo uma seqúência que codifica uma parte de uma glicoproteína de lissavírus contendo pelo menos o sítio iii da glicoproteína de lissavírus mas não contendo o sítio ii, e, composição imunogênica